Gastrointestinal tumor patients with CD3+ T cell infiltration showed a higher rate of progression-free survival (311), and pancreatic adenocarcinomas containing both CD4+ and CD8+ T cells correlated with an improved prognosis and significantly greater 5-year survival (181, 312, 313). Here, CD8A is linked to pancreatic adenocarcinoma.